Cognition and cancer:
Most people afflicted by cancer will experience cognitive impairment, sometimes referred to as 'chemobrain' or 'chemofog', due to the various direct and indirect effects of their disease and its treatment. In addition, patients with primary or metastatic tumors of the brain exper...
Gespeichert in:
| Weitere Verfasser: | , |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Cambridge
Cambridge University Press
2008
|
| Schlagworte: | |
| Online-Zugang: | BSB01 FHN01 Volltext |
| Zusammenfassung: | Most people afflicted by cancer will experience cognitive impairment, sometimes referred to as 'chemobrain' or 'chemofog', due to the various direct and indirect effects of their disease and its treatment. In addition, patients with primary or metastatic tumors of the brain experience direct neurologic symptoms due, for example, to the location of their disease, surgical intervention, and the late effects of treatment such as radiotherapy. The aim of this book is to serve as a resource for health care professionals working with cancer patients who experience cognitive changes as a result of their cancer and its treatment. It provides practical information to help improve care by reviewing and describing brain-behavior relationships; research-based evidence on cognitive changes that occur with various cancers and cancer treatments; assessment techniques, including neurocognitive assessment and neuroimaging techniques; and intervention strategies for affected patients. In short, it will explain how to identify, assess and treat these conditions |
| Beschreibung: | Title from publisher's bibliographic system (viewed on 05 Oct 2015) |
| Beschreibung: | 1 online resource (xii, 341 pages) |
| ISBN: | 9780511545900 |
| DOI: | 10.1017/CBO9780511545900 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV043944690 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 161206s2008 |||| o||u| ||||||eng d | ||
| 020 | |a 9780511545900 |c Online |9 978-0-511-54590-0 | ||
| 024 | 7 | |a 10.1017/CBO9780511545900 |2 doi | |
| 035 | |a (ZDB-20-CBO)CR9780511545900 | ||
| 035 | |a (OCoLC)850882122 | ||
| 035 | |a (DE-599)BVBBV043944690 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-12 |a DE-92 | ||
| 082 | 0 | |a 616.99406 |2 22 | |
| 245 | 1 | 0 | |a Cognition and cancer |c edited by Christina A. Meyers, James R. Perry |
| 246 | 1 | 3 | |a Cognition & Cancer |
| 264 | 1 | |a Cambridge |b Cambridge University Press |c 2008 | |
| 300 | |a 1 online resource (xii, 341 pages) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 500 | |a Title from publisher's bibliographic system (viewed on 05 Oct 2015) | ||
| 505 | 8 | |a Clinical neuropsychology / Jill B. Rich and Angela K. Troyer -- Brain imaging investigation of chemotherapy-induced neurocognitive changes / Brenna C. McDonald, Andrew J. Saykin, and Tim A. Ahles -- Role of neuropsychological assessment in cancer patients / Elana Farace -- Neuropsychological assessment of adults with cancer / Anne E. Kayl, Robert Collins, and Jeffrey S. Wefel -- Neuropsychological assessment of children with cancer / Louise Penkman Fennell and Robert W. Butler -- Biological bases of radiation injury to the brain / Edward G. Shaw and Mike E. Robbins -- Chemotherapy and biological response modifier-related cognitive dysfunction / Jeffrey S. Wefel, Robert Collins, and Anne E. Kayl -- Effect of hormones and hormonal treatment on cognition / Christien Schilder, Sanne Schagen, and Frits Van Dam -- Low grade gliomas / Martin J. B. Taphoorn and Charles G. Niel -- High grade gliomas / Michael J. Glantz and John Conlee -- Brain metastases / Deepak Khuntia ... [et al.] -- Primary central nervous system lymphoma / Denise D. Correa -- Childhood brain tumors / H. Stacy Nicholson, Louise Penkman Fennell, and Robert W. Butler -- Neurofibromatosis / Bartlett D. Moore III and John M. Slopis -- Hematological malignancies / Melissa Friedman and Mercedes Fernandez -- Paraneoplastic disorders / Edward Dropcho -- Symptomatic therapies and supportive care issues / Alan Valentine and Eduardo Bruera -- Animal models and cancer related symptoms / Adrian Dunn -- Behavioral strategies and rehabilitation / Dona E.C. Locke, Jane H. Cerhan, and James F. Malec -- Support services / Bebe Guill and Renee H. Raynor -- Pharmacologic interventions for the treatment of radiation-induced brain injury / Edward G. Shaw ... [et al.] -- Neurocognitive testing in clinical trials / Jennifer A. Smith and Jeffrey S. Wefel | |
| 520 | |a Most people afflicted by cancer will experience cognitive impairment, sometimes referred to as 'chemobrain' or 'chemofog', due to the various direct and indirect effects of their disease and its treatment. In addition, patients with primary or metastatic tumors of the brain experience direct neurologic symptoms due, for example, to the location of their disease, surgical intervention, and the late effects of treatment such as radiotherapy. The aim of this book is to serve as a resource for health care professionals working with cancer patients who experience cognitive changes as a result of their cancer and its treatment. It provides practical information to help improve care by reviewing and describing brain-behavior relationships; research-based evidence on cognitive changes that occur with various cancers and cancer treatments; assessment techniques, including neurocognitive assessment and neuroimaging techniques; and intervention strategies for affected patients. In short, it will explain how to identify, assess and treat these conditions | ||
| 650 | 4 | |a Cancer / Complications | |
| 650 | 4 | |a Cancer / Treatment / Complications | |
| 650 | 4 | |a Cognition disorders / Etiology | |
| 650 | 0 | 7 | |a Kognitive Störung |0 (DE-588)4164473-6 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Kognitive Psychologie |0 (DE-588)4073586-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Arzneimittelnebenwirkung |0 (DE-588)4003134-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Cytostatikum |0 (DE-588)4068347-3 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Sekundärkrankheit |0 (DE-588)4131705-1 |2 gnd |9 rswk-swf |
| 655 | 7 | |8 1\p |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
| 689 | 0 | 0 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |D s |
| 689 | 0 | 1 | |a Sekundärkrankheit |0 (DE-588)4131705-1 |D s |
| 689 | 0 | 2 | |a Kognitive Störung |0 (DE-588)4164473-6 |D s |
| 689 | 0 | |8 2\p |5 DE-604 | |
| 689 | 1 | 0 | |a Cytostatikum |0 (DE-588)4068347-3 |D s |
| 689 | 1 | 1 | |a Arzneimittelnebenwirkung |0 (DE-588)4003134-2 |D s |
| 689 | 1 | 2 | |a Kognitive Störung |0 (DE-588)4164473-6 |D s |
| 689 | 1 | |8 3\p |5 DE-604 | |
| 689 | 2 | 0 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |D s |
| 689 | 2 | 1 | |a Kognitive Psychologie |0 (DE-588)4073586-2 |D s |
| 689 | 2 | |8 4\p |5 DE-604 | |
| 700 | 1 | |a Meyers, Christina A. |4 edt | |
| 700 | 1 | |a Perry, James R. |4 edt | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druckausgabe |z 978-0-521-85482-5 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druckausgabe |z 978-1-107-41181-4 |
| 856 | 4 | 0 | |u https://doi.org/10.1017/CBO9780511545900 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
| 912 | |a ZDB-20-CBO | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-029353661 | ||
| 883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 883 | 1 | |8 2\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 883 | 1 | |8 3\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 883 | 1 | |8 4\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 966 | e | |u https://doi.org/10.1017/CBO9780511545900 |l BSB01 |p ZDB-20-CBO |q BSB_PDA_CBO |x Verlag |3 Volltext | |
| 966 | e | |u https://doi.org/10.1017/CBO9780511545900 |l FHN01 |p ZDB-20-CBO |q FHN_PDA_CBO |x Verlag |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804176889882869760 |
|---|---|
| any_adam_object | |
| author2 | Meyers, Christina A. Perry, James R. |
| author2_role | edt edt |
| author2_variant | c a m ca cam j r p jr jrp |
| author_facet | Meyers, Christina A. Perry, James R. |
| building | Verbundindex |
| bvnumber | BV043944690 |
| collection | ZDB-20-CBO |
| contents | Clinical neuropsychology / Jill B. Rich and Angela K. Troyer -- Brain imaging investigation of chemotherapy-induced neurocognitive changes / Brenna C. McDonald, Andrew J. Saykin, and Tim A. Ahles -- Role of neuropsychological assessment in cancer patients / Elana Farace -- Neuropsychological assessment of adults with cancer / Anne E. Kayl, Robert Collins, and Jeffrey S. Wefel -- Neuropsychological assessment of children with cancer / Louise Penkman Fennell and Robert W. Butler -- Biological bases of radiation injury to the brain / Edward G. Shaw and Mike E. Robbins -- Chemotherapy and biological response modifier-related cognitive dysfunction / Jeffrey S. Wefel, Robert Collins, and Anne E. Kayl -- Effect of hormones and hormonal treatment on cognition / Christien Schilder, Sanne Schagen, and Frits Van Dam -- Low grade gliomas / Martin J. B. Taphoorn and Charles G. Niel -- High grade gliomas / Michael J. Glantz and John Conlee -- Brain metastases / Deepak Khuntia ... [et al.] -- Primary central nervous system lymphoma / Denise D. Correa -- Childhood brain tumors / H. Stacy Nicholson, Louise Penkman Fennell, and Robert W. Butler -- Neurofibromatosis / Bartlett D. Moore III and John M. Slopis -- Hematological malignancies / Melissa Friedman and Mercedes Fernandez -- Paraneoplastic disorders / Edward Dropcho -- Symptomatic therapies and supportive care issues / Alan Valentine and Eduardo Bruera -- Animal models and cancer related symptoms / Adrian Dunn -- Behavioral strategies and rehabilitation / Dona E.C. Locke, Jane H. Cerhan, and James F. Malec -- Support services / Bebe Guill and Renee H. Raynor -- Pharmacologic interventions for the treatment of radiation-induced brain injury / Edward G. Shaw ... [et al.] -- Neurocognitive testing in clinical trials / Jennifer A. Smith and Jeffrey S. Wefel |
| ctrlnum | (ZDB-20-CBO)CR9780511545900 (OCoLC)850882122 (DE-599)BVBBV043944690 |
| dewey-full | 616.99406 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.99406 |
| dewey-search | 616.99406 |
| dewey-sort | 3616.99406 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| doi_str_mv | 10.1017/CBO9780511545900 |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>05941nmm a2200721zc 4500</leader><controlfield tag="001">BV043944690</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">161206s2008 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780511545900</subfield><subfield code="c">Online</subfield><subfield code="9">978-0-511-54590-0</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1017/CBO9780511545900</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-20-CBO)CR9780511545900</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)850882122</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV043944690</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-92</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.99406</subfield><subfield code="2">22</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Cognition and cancer</subfield><subfield code="c">edited by Christina A. Meyers, James R. Perry</subfield></datafield><datafield tag="246" ind1="1" ind2="3"><subfield code="a">Cognition & Cancer</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Cambridge</subfield><subfield code="b">Cambridge University Press</subfield><subfield code="c">2008</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (xii, 341 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Title from publisher's bibliographic system (viewed on 05 Oct 2015)</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Clinical neuropsychology / Jill B. Rich and Angela K. Troyer -- Brain imaging investigation of chemotherapy-induced neurocognitive changes / Brenna C. McDonald, Andrew J. Saykin, and Tim A. Ahles -- Role of neuropsychological assessment in cancer patients / Elana Farace -- Neuropsychological assessment of adults with cancer / Anne E. Kayl, Robert Collins, and Jeffrey S. Wefel -- Neuropsychological assessment of children with cancer / Louise Penkman Fennell and Robert W. Butler -- Biological bases of radiation injury to the brain / Edward G. Shaw and Mike E. Robbins -- Chemotherapy and biological response modifier-related cognitive dysfunction / Jeffrey S. Wefel, Robert Collins, and Anne E. Kayl -- Effect of hormones and hormonal treatment on cognition / Christien Schilder, Sanne Schagen, and Frits Van Dam -- Low grade gliomas / Martin J. B. Taphoorn and Charles G. Niel -- High grade gliomas / Michael J. Glantz and John Conlee -- Brain metastases / Deepak Khuntia ... [et al.] -- Primary central nervous system lymphoma / Denise D. Correa -- Childhood brain tumors / H. Stacy Nicholson, Louise Penkman Fennell, and Robert W. Butler -- Neurofibromatosis / Bartlett D. Moore III and John M. Slopis -- Hematological malignancies / Melissa Friedman and Mercedes Fernandez -- Paraneoplastic disorders / Edward Dropcho -- Symptomatic therapies and supportive care issues / Alan Valentine and Eduardo Bruera -- Animal models and cancer related symptoms / Adrian Dunn -- Behavioral strategies and rehabilitation / Dona E.C. Locke, Jane H. Cerhan, and James F. Malec -- Support services / Bebe Guill and Renee H. Raynor -- Pharmacologic interventions for the treatment of radiation-induced brain injury / Edward G. Shaw ... [et al.] -- Neurocognitive testing in clinical trials / Jennifer A. Smith and Jeffrey S. Wefel</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Most people afflicted by cancer will experience cognitive impairment, sometimes referred to as 'chemobrain' or 'chemofog', due to the various direct and indirect effects of their disease and its treatment. In addition, patients with primary or metastatic tumors of the brain experience direct neurologic symptoms due, for example, to the location of their disease, surgical intervention, and the late effects of treatment such as radiotherapy. The aim of this book is to serve as a resource for health care professionals working with cancer patients who experience cognitive changes as a result of their cancer and its treatment. It provides practical information to help improve care by reviewing and describing brain-behavior relationships; research-based evidence on cognitive changes that occur with various cancers and cancer treatments; assessment techniques, including neurocognitive assessment and neuroimaging techniques; and intervention strategies for affected patients. In short, it will explain how to identify, assess and treat these conditions</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cancer / Complications</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cancer / Treatment / Complications</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cognition disorders / Etiology</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Kognitive Störung</subfield><subfield code="0">(DE-588)4164473-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Kognitive Psychologie</subfield><subfield code="0">(DE-588)4073586-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelnebenwirkung</subfield><subfield code="0">(DE-588)4003134-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Cytostatikum</subfield><subfield code="0">(DE-588)4068347-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Sekundärkrankheit</subfield><subfield code="0">(DE-588)4131705-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="8">1\p</subfield><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Sekundärkrankheit</subfield><subfield code="0">(DE-588)4131705-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Kognitive Störung</subfield><subfield code="0">(DE-588)4164473-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="8">2\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Cytostatikum</subfield><subfield code="0">(DE-588)4068347-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Arzneimittelnebenwirkung</subfield><subfield code="0">(DE-588)4003134-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="2"><subfield code="a">Kognitive Störung</subfield><subfield code="0">(DE-588)4164473-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="8">3\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="2" ind2="0"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="1"><subfield code="a">Kognitive Psychologie</subfield><subfield code="0">(DE-588)4073586-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2=" "><subfield code="8">4\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Meyers, Christina A.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Perry, James R.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druckausgabe</subfield><subfield code="z">978-0-521-85482-5</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druckausgabe</subfield><subfield code="z">978-1-107-41181-4</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1017/CBO9780511545900</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-20-CBO</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-029353661</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">2\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">3\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">4\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1017/CBO9780511545900</subfield><subfield code="l">BSB01</subfield><subfield code="p">ZDB-20-CBO</subfield><subfield code="q">BSB_PDA_CBO</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1017/CBO9780511545900</subfield><subfield code="l">FHN01</subfield><subfield code="p">ZDB-20-CBO</subfield><subfield code="q">FHN_PDA_CBO</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| genre | 1\p (DE-588)4143413-4 Aufsatzsammlung gnd-content |
| genre_facet | Aufsatzsammlung |
| id | DE-604.BV043944690 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T07:39:22Z |
| institution | BVB |
| isbn | 9780511545900 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-029353661 |
| oclc_num | 850882122 |
| open_access_boolean | |
| owner | DE-12 DE-92 |
| owner_facet | DE-12 DE-92 |
| physical | 1 online resource (xii, 341 pages) |
| psigel | ZDB-20-CBO ZDB-20-CBO BSB_PDA_CBO ZDB-20-CBO FHN_PDA_CBO |
| publishDate | 2008 |
| publishDateSearch | 2008 |
| publishDateSort | 2008 |
| publisher | Cambridge University Press |
| record_format | marc |
| spelling | Cognition and cancer edited by Christina A. Meyers, James R. Perry Cognition & Cancer Cambridge Cambridge University Press 2008 1 online resource (xii, 341 pages) txt rdacontent c rdamedia cr rdacarrier Title from publisher's bibliographic system (viewed on 05 Oct 2015) Clinical neuropsychology / Jill B. Rich and Angela K. Troyer -- Brain imaging investigation of chemotherapy-induced neurocognitive changes / Brenna C. McDonald, Andrew J. Saykin, and Tim A. Ahles -- Role of neuropsychological assessment in cancer patients / Elana Farace -- Neuropsychological assessment of adults with cancer / Anne E. Kayl, Robert Collins, and Jeffrey S. Wefel -- Neuropsychological assessment of children with cancer / Louise Penkman Fennell and Robert W. Butler -- Biological bases of radiation injury to the brain / Edward G. Shaw and Mike E. Robbins -- Chemotherapy and biological response modifier-related cognitive dysfunction / Jeffrey S. Wefel, Robert Collins, and Anne E. Kayl -- Effect of hormones and hormonal treatment on cognition / Christien Schilder, Sanne Schagen, and Frits Van Dam -- Low grade gliomas / Martin J. B. Taphoorn and Charles G. Niel -- High grade gliomas / Michael J. Glantz and John Conlee -- Brain metastases / Deepak Khuntia ... [et al.] -- Primary central nervous system lymphoma / Denise D. Correa -- Childhood brain tumors / H. Stacy Nicholson, Louise Penkman Fennell, and Robert W. Butler -- Neurofibromatosis / Bartlett D. Moore III and John M. Slopis -- Hematological malignancies / Melissa Friedman and Mercedes Fernandez -- Paraneoplastic disorders / Edward Dropcho -- Symptomatic therapies and supportive care issues / Alan Valentine and Eduardo Bruera -- Animal models and cancer related symptoms / Adrian Dunn -- Behavioral strategies and rehabilitation / Dona E.C. Locke, Jane H. Cerhan, and James F. Malec -- Support services / Bebe Guill and Renee H. Raynor -- Pharmacologic interventions for the treatment of radiation-induced brain injury / Edward G. Shaw ... [et al.] -- Neurocognitive testing in clinical trials / Jennifer A. Smith and Jeffrey S. Wefel Most people afflicted by cancer will experience cognitive impairment, sometimes referred to as 'chemobrain' or 'chemofog', due to the various direct and indirect effects of their disease and its treatment. In addition, patients with primary or metastatic tumors of the brain experience direct neurologic symptoms due, for example, to the location of their disease, surgical intervention, and the late effects of treatment such as radiotherapy. The aim of this book is to serve as a resource for health care professionals working with cancer patients who experience cognitive changes as a result of their cancer and its treatment. It provides practical information to help improve care by reviewing and describing brain-behavior relationships; research-based evidence on cognitive changes that occur with various cancers and cancer treatments; assessment techniques, including neurocognitive assessment and neuroimaging techniques; and intervention strategies for affected patients. In short, it will explain how to identify, assess and treat these conditions Cancer / Complications Cancer / Treatment / Complications Cognition disorders / Etiology Kognitive Störung (DE-588)4164473-6 gnd rswk-swf Krebs Medizin (DE-588)4073781-0 gnd rswk-swf Kognitive Psychologie (DE-588)4073586-2 gnd rswk-swf Arzneimittelnebenwirkung (DE-588)4003134-2 gnd rswk-swf Cytostatikum (DE-588)4068347-3 gnd rswk-swf Sekundärkrankheit (DE-588)4131705-1 gnd rswk-swf 1\p (DE-588)4143413-4 Aufsatzsammlung gnd-content Krebs Medizin (DE-588)4073781-0 s Sekundärkrankheit (DE-588)4131705-1 s Kognitive Störung (DE-588)4164473-6 s 2\p DE-604 Cytostatikum (DE-588)4068347-3 s Arzneimittelnebenwirkung (DE-588)4003134-2 s 3\p DE-604 Kognitive Psychologie (DE-588)4073586-2 s 4\p DE-604 Meyers, Christina A. edt Perry, James R. edt Erscheint auch als Druckausgabe 978-0-521-85482-5 Erscheint auch als Druckausgabe 978-1-107-41181-4 https://doi.org/10.1017/CBO9780511545900 Verlag URL des Erstveröffentlichers Volltext 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 2\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 3\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 4\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
| spellingShingle | Cognition and cancer Clinical neuropsychology / Jill B. Rich and Angela K. Troyer -- Brain imaging investigation of chemotherapy-induced neurocognitive changes / Brenna C. McDonald, Andrew J. Saykin, and Tim A. Ahles -- Role of neuropsychological assessment in cancer patients / Elana Farace -- Neuropsychological assessment of adults with cancer / Anne E. Kayl, Robert Collins, and Jeffrey S. Wefel -- Neuropsychological assessment of children with cancer / Louise Penkman Fennell and Robert W. Butler -- Biological bases of radiation injury to the brain / Edward G. Shaw and Mike E. Robbins -- Chemotherapy and biological response modifier-related cognitive dysfunction / Jeffrey S. Wefel, Robert Collins, and Anne E. Kayl -- Effect of hormones and hormonal treatment on cognition / Christien Schilder, Sanne Schagen, and Frits Van Dam -- Low grade gliomas / Martin J. B. Taphoorn and Charles G. Niel -- High grade gliomas / Michael J. Glantz and John Conlee -- Brain metastases / Deepak Khuntia ... [et al.] -- Primary central nervous system lymphoma / Denise D. Correa -- Childhood brain tumors / H. Stacy Nicholson, Louise Penkman Fennell, and Robert W. Butler -- Neurofibromatosis / Bartlett D. Moore III and John M. Slopis -- Hematological malignancies / Melissa Friedman and Mercedes Fernandez -- Paraneoplastic disorders / Edward Dropcho -- Symptomatic therapies and supportive care issues / Alan Valentine and Eduardo Bruera -- Animal models and cancer related symptoms / Adrian Dunn -- Behavioral strategies and rehabilitation / Dona E.C. Locke, Jane H. Cerhan, and James F. Malec -- Support services / Bebe Guill and Renee H. Raynor -- Pharmacologic interventions for the treatment of radiation-induced brain injury / Edward G. Shaw ... [et al.] -- Neurocognitive testing in clinical trials / Jennifer A. Smith and Jeffrey S. Wefel Cancer / Complications Cancer / Treatment / Complications Cognition disorders / Etiology Kognitive Störung (DE-588)4164473-6 gnd Krebs Medizin (DE-588)4073781-0 gnd Kognitive Psychologie (DE-588)4073586-2 gnd Arzneimittelnebenwirkung (DE-588)4003134-2 gnd Cytostatikum (DE-588)4068347-3 gnd Sekundärkrankheit (DE-588)4131705-1 gnd |
| subject_GND | (DE-588)4164473-6 (DE-588)4073781-0 (DE-588)4073586-2 (DE-588)4003134-2 (DE-588)4068347-3 (DE-588)4131705-1 (DE-588)4143413-4 |
| title | Cognition and cancer |
| title_alt | Cognition & Cancer |
| title_auth | Cognition and cancer |
| title_exact_search | Cognition and cancer |
| title_full | Cognition and cancer edited by Christina A. Meyers, James R. Perry |
| title_fullStr | Cognition and cancer edited by Christina A. Meyers, James R. Perry |
| title_full_unstemmed | Cognition and cancer edited by Christina A. Meyers, James R. Perry |
| title_short | Cognition and cancer |
| title_sort | cognition and cancer |
| topic | Cancer / Complications Cancer / Treatment / Complications Cognition disorders / Etiology Kognitive Störung (DE-588)4164473-6 gnd Krebs Medizin (DE-588)4073781-0 gnd Kognitive Psychologie (DE-588)4073586-2 gnd Arzneimittelnebenwirkung (DE-588)4003134-2 gnd Cytostatikum (DE-588)4068347-3 gnd Sekundärkrankheit (DE-588)4131705-1 gnd |
| topic_facet | Cancer / Complications Cancer / Treatment / Complications Cognition disorders / Etiology Kognitive Störung Krebs Medizin Kognitive Psychologie Arzneimittelnebenwirkung Cytostatikum Sekundärkrankheit Aufsatzsammlung |
| url | https://doi.org/10.1017/CBO9780511545900 |
| work_keys_str_mv | AT meyerschristinaa cognitionandcancer AT perryjamesr cognitionandcancer AT meyerschristinaa cognitioncancer AT perryjamesr cognitioncancer |